- Home
- YDKG vs PULM Comparison
YDKG vs PULM Comparison
Compare YDKG & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | YDKG | PULM |
|---|---|---|
| Founded | 2005 | 2003 |
| Country | China | United States |
| Employees | 18 | N/A |
| Industry | Advertising | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3M | 6.1M |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | YDKG | PULM |
|---|---|---|
| Price | $1.08 | $1.74 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 24.9K | 16.3K |
| Earning Date | 05-12-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 46.18 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $7,910,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 5069.93 |
| 52 Week Low | $0.02 | $1.16 |
| 52 Week High | $3.90 | $5.58 |
Technical Indicators
Market Signals| Indicator | YDKG | PULM |
|---|---|---|
| Relative Strength Index (RSI) | 63.13 | 57.46 |
| Support Level | $0.81 | $1.59 |
| Resistance Level | $1.13 | $1.84 |
| Average True Range (ATR) | 0.07 | 0.08 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 90.48 | 79.22 |
Price Performance
Historical ComparisonAbout YDKG Yueda Digital Holding Class A Ordinary Share
Yueda Digital Holding is a Web3 and digital company with a focus on the long-term accumulation of mainstream cryptocurrencies. The business activities of the company include active treasury management of mainstream digital assets, exploration of compliant, risk-managed yield opportunities, such as staking, on-chain liquidity provision, and other conservative market activities, selective investments and partnerships in Web3 infrastructure and applications, and advisory services for enterprises entering the digital-asset economy.
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).